ORX:STO
Orexo AB
1,37 SEK
arrow_downward
-1,58%(-0,022) 1D
6 қар., 17:29:49 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
1,47 SEK
High
1,47 SEK
Low
1,31 SEK
Mkt. cap
48,05 млн
Avg. vol.
320,60 м.
Volume
525,28 м.
P/E ratio
0,06
52-wk high
36,00 SEK
52-wk low
1,30 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
1,47 SEK
High
1,47 SEK
Low
1,31 SEK
Mkt. cap
48,05 млн
Avg. vol.
320,60 м.
Volume
525,28 м.
P/E ratio
0,06
52-wk high
36,00 SEK
52-wk low
1,30 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
ABC10
·
4 минут бұрын
Tech stock sell-off raises questions about AI boom and data center growth | Dollars & Sense
Yahoo Finance
·
43 минут бұрын
5 Best 52-Week Low NASDAQ Stocks to Buy According to Billionaires
TradingKey
·
44 минут бұрын
S&P 500 Sees Nearly Zero Gains in Five Months: Valuation Drops to 18.5 Times, Are US Stocks Getting Cheaper?
Investor's Business Daily
·
1 сағат бұрын
Futures: Market Needs Repair; These Big Winners Are Broken
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com